LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 88.84 | 27.76 | 508 | 6965 | 0.0729 | 0.4401 | MN20160318_Q01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 88.84 | 27.76 | 4334 | 6965 | 0.6223 | 0.8844 | MN20160318_Q01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 88.84 | 27.76 | 588 | 6965 | 0.0844 | 0.4667 | MN20160318_Q01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 88.84 | 27.76 | 4617 | 6965 | 0.6629 | 0.8995 | MN20160318_Q01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 90.55 | 27.76 | 488 | 6928 | 0.0704 | 0.4333 | MN20160318_Q01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 90.55 | 27.76 | 4427 | 6928 | 0.6389 | 0.8906 | MN20160318_Q01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 90.55 | 27.76 | 645 | 6928 | 0.0931 | 0.4844 | MN20160318_Q01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 90.55 | 27.76 | 4733 | 6928 | 0.6831 | 0.9065 | MN20160318_Q01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 92.25 | 27.76 | 375 | 6873 | 0.0546 | 0.3873 | MN20160318_Q01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 92.25 | 27.76 | 4437 | 6873 | 0.6455 | 0.8929 | MN20160318_Q01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 92.25 | 27.76 | 605 | 6873 | 0.0880 | 0.4734 | MN20160318_Q01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 92.25 | 27.76 | 4799 | 6873 | 0.6982 | 0.9117 | MN20160318_Q01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 93.96 | 27.76 | 357 | 6849 | 0.0521 | 0.3791 | MN20160318_Q01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 93.96 | 27.76 | 4559 | 6849 | 0.6656 | 0.9002 | MN20160318_Q01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 93.96 | 27.76 | 651 | 6849 | 0.0950 | 0.4874 | MN20160318_Q01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 93.96 | 27.76 | 4923 | 6849 | 0.7188 | 0.9186 | MN20160318_Q01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 95.66 | 27.76 | 370 | 6712 | 0.0551 | 0.3870 | MN20160318_Q01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 95.66 | 27.76 | 4657 | 6712 | 0.6938 | 0.9098 | MN20160318_Q01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 95.66 | 27.76 | 675 | 6712 | 0.1006 | 0.4964 | MN20160318_Q01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 95.66 | 27.76 | 5004 | 6712 | 0.7455 | 0.9272 | MN20160318_Q01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 1.95 | 27.76 | 1 | 225 | 0.0044 | -0.6673 | MN20160318_Q01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 1.95 | 27.76 | 299 | 225 | 1.3280 | 1.1970 | MN20160318_Q01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 1.95 | 27.76 | 1 | 225 | 0.0044 | -0.6673 | MN20160318_Q01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 1.95 | 27.76 | 383 | 225 | 1.7011 | 1.3847 | MN20160318_Q01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 3.66 | 27.76 | 1 | 283 | 0.0035 | -0.6287 | MN20160318_Q01 | E05 |